ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Dipharma, an Italian pharmaceutical chemical firm, has installed a kilo lab and quality-control lab, both certified under the US Food and Drug Administration’s current good manufacturing practice standard, at its US subsidiary Kalexsynin Kalamazoo, Michigan. The new assets will allow Dipharma to pursue Phase I and early–Phase II clinical supply projects. “Dipharma Group is now able to cover the whole pharmaceutical chemistry services spectrum,” says Dipharma CEO Jorge Nogueira. Dipharma acquired Kalexsyn in 2018.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X